Administration of the GLP‐1R analog Ex‐4 and the DPP‐4 inhibitor saxagliptin for 8 weeks significantly decreased plasma glucose levels and improved glucose tolerance compared with the diabetic mice (DM) group (Figure 1b,c). Here, GLP1R is linked to glucose measurement.